AORT — ARTIVION INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying AORT?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their AORT position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +3 tracked investors added or increased positions last quarter (Izzy Englander, Steve Cohen, Ken Griffin)
- +3 tracked investors reported holding AORT at their latest filing
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About ARTIVION INC (AORT)
ARTIVION INC (AORT) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $26M. Across recent filings, tracked investors recorded 6 new positions, 9 increased, 6 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in AORT
How many top investors track AORT
A small number of top investors own this.
AORT Ownership Composition
How ARTIVION INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting AORT
1 tracked investor has since exited this position — listed separately below.
- Ken GriffinSep 30, 2026Citadel AdvisorsShares1.1MValue$26.1M% Portfolio0.00%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares559.1KValue$12.8M% Portfolio0.00%
- Steve CohenSep 30, 2026Point72 Asset ManagementShares41.5KValue$947.8K% Portfolio0.00%
Previously held AORT
These investors reported AORT in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | 68K | $2.9M | Sep 30, 2025 |
Recent activity
- $12.8MNov 16, 2026
- New$947.8KNov 16, 2026
- Increased$26.1M(38.13%)Nov 16, 2026
- Reduced$3.5M(-72.79%)Nov 14, 2024
- Increased$4.7M(25.12%)Feb 14, 2025
- Reduced$3.9M(-3.12%)May 15, 2025
- Reduced$4.4M(-11.28%)Aug 14, 2025
- Increased$4.2M(0.98%)Feb 17, 2026
- Sold$0(-100.00%)May 15, 2026
- Reduced$1.3M(-19.29%)Nov 14, 2024
- Increased$808.1K(2.10%)May 15, 2025
- Increased$5.4M(424.23%)Aug 14, 2025
- Sold$0(-100.00%)Nov 14, 2025
- Increased$18.6M(1067.78%)Aug 14, 2026
- New$5.6MFeb 14, 2025
- Sold$0(-100.00%)Jul 21, 2025
- $1.8MAug 14, 2024
- Increased$3.8M(109.24%)Nov 14, 2024
- Increased$5.1M(22.99%)Feb 14, 2025
- Increased$5.8M(32.72%)May 15, 2025
- Reduced$3.3M(-54.29%)Aug 14, 2025
- Reduced$2.9M(-36.67%)Dec 9, 2025
- New$1.5MAug 14, 2024
- $10.7MMay 15, 2024
Frequently asked questions
- How many institutional investors hold AORT?
- 3 tracked institutional investors disclosed a position in AORT (ARTIVION INC) in their most recent 13F filing.
- Who is the largest institutional holder of AORT?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in AORT, valued at $26M.
- Did institutional ownership of AORT increase or decrease?
- Across recent 13F filings, tracked investors recorded 6 new positions, 9 increased, 6 reduced, and 3 fully exited AORT.
- Where does this AORT ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.